Month: November 2016

Pharma / Biotech is one of the most M&A intensive industries. Over a period of approximately 20 years, the industry has spent over USD 1.4 trillion in pharma / biotech acquisitions (excl. generics, OTC, Animal Health, CROs and CMOs acquisitions). The aim of this analysis is to assess which of the acquirers have really gained from…… Continue reading Winners and Losers in Pharma / Biotech Mergers and Acquisitions: Biogen Shines Again

Brand valuation is a major part of business valuation in certain industries such as food & beverage and consumer home products. For example, Coca-Cola’s brand value is estimated at USD 73 bn. (see here), accounting for 40% of Coca-Cola’s current market capitalization. But how does brand valuation apply in the context of pharmaceuticals? In theory, a…… Continue reading Brand Valuation of OTC Pharmaceutical Businesses